Biodesix, Inc. (BDSX)
NASDAQ: BDSX · Real-Time Price · USD
13.79
-0.42 (-2.96%)
Mar 30, 2026, 4:00 PM EDT - Market closed
Biodesix Market Cap
Biodesix has a market cap or net worth of $135.95 million as of March 31, 2026. Its market cap has increased by 28.97% in one year.
Market Cap
135.95M
Enterprise Value
191.99M
1-Year Change
28.97%
Ranking
Category
Stock Price
$13.79
Market Cap Chart
Since October 28, 2020, Biodesix's market cap has decreased from $336.31M to $135.95M, a decrease of -59.58%. That is a compound annual growth rate of -15.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 135.95M | 151.29% |
| Dec 31, 2025 | 54.10M | -75.69% |
| Dec 31, 2024 | 222.56M | 33.69% |
| Dec 29, 2023 | 166.48M | -5.38% |
| Dec 30, 2022 | 175.94M | 23.06% |
| Dec 31, 2021 | 142.97M | -73.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Castle Biosciences | 700.17M |
| Personalis | 652.90M |
| Fulgent Genetics | 488.13M |
| Myriad Genetics | 407.70M |
| Prenetics Global | 335.73M |
| Burning Rock Biotech | 172.27M |
| FONAR | 121.67M |
| MDxHealth | 117.62M |